Exclusive

Publication

Byline

Singapore Clinical Trial: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemotherapy (modified FOLFIRINOX or Gemcitabine plus Nab-paclitaxel) with or without Zoldonrasib (RMC 9805) as First-line Treatment in Patients with Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma (RASolute 305)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Investigator Choice of Chemother... Read More


Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose S... Read More


IPS Academy Hosts Five-Day Induction Programme 'Aavahan 2026' at North Campus

New Delhi, Sept. 21 -- Indore (Madhya Pradesh) [India], September 19: IPS Academy, Indore-Ujjain Road North Campus , organised the five-day induction and orientation programme "Aavahan... Read More


As key DPDP compliance milestones approach, 250 founders and 35 investors gather in Bengaluru to make privacy a growth strategy

Bhubaneswar, Sept. 21 -- The DPDP Zone summit drew 350 attendees, including 250 founders, while 15 startups pitched at an invite-only Demo Session. Bengaluru, 21 September 2026: DPDP Zone's Privacy b... Read More


Tata boardroom battle raises new question who will pay legal bills

Goa, Sept. 21 -- The escalating dispute between Tata Trusts and Tata Sons over N Chandrasekaran's reappointment has raised a new question: who will pay for the legal battle if the conflict goes to cou... Read More


Kailash Vijayvargiya's weight remark on BJP councillor sparks row in Indore

Goa, Sept. 21 -- A remark by Madhya Pradesh minister Kailash Vijayvargiya about BJP councillor Sandhya Yadav's appearance at a public programme in Indore has triggered a political controversy, after a... Read More


Asian Games: Himanshu silver lining in India's air rifle medals

India, Sept. 21 -- By the time their adrenaline settled, Himanshu Dhillon and Rudrankksh Patil were left pondering over what they had achieved as well as what they could have done. Rudrankksh spoke ab... Read More


Singapore Clinical Trial: A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis (stage F4 fibrosis) due to metabolic dysfunction-associated steatohepatitis (NEBULA-2)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, two-part, double-blind, randomized, placebo-controlled study to investigate the safety... Read More


Singapore Clinical Trial: A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety and efficacy of efimosfermin alfa injection in adult participants with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (NEBULA-1)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, double-blind, randomized, placebo controlled, 2-arm study to investigate the safety an... Read More


Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More